Our Family Our Future: Acceptability and Feasibility Study of a Family Prevention Program for HIV Risk and Depression

July 31, 2017 updated by: Caroline Kuo, Brown University

Our Family Our Future: Family Prevention of HIV Risk and Depression in HIV-endemic South Africa

The purpose of this study is to assess the feasibility and acceptability of a family-based preventive intervention designed to reduce sexual risk behaviors and depressive symptoms among South African adolescents and their parents/guardians/caregivers.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

The Our Family Our Future Program is a preventive intervention program designed to prevent or reduce adolescent sexual risk behavior and to increase mental health resilience against depression onset among adolescents (13-15 years of age). The intervention takes a family approach and addresses HIV risk and depression in an integrated model. HIV and depression are the leading causes of global burden of disease in low and middle income countries. The intervention is being tested in South Africa, the country confronting the largest HIV epidemic in the world and because preliminary studies with South African families identified poor mental health and sexual risk behavior as priority areas for preventive intervention development and testing.

This study is a randomized pilot design, where 152 adolescents and parents will be randomly assigned to an intervention condition or a standard usual care condition and then offered the experimental intervention as on a wait-list. Families will be recruited and screened for eligibility based on systematic house-to-house recruitment in the community. Eligibility is based on dyadic eligibility and includes age criteria, consistent presence in the household, depressive symptoms that fall below clinically significant threshold criteria, and ability to provide informed consent and assent. Eligible families will be randomized and offered a preventive intervention program in a group format, led by program facilitators in a community setting. The intervention program consists of 3 sessions plus an individualized family meeting. In some modules parents/guardians/caregivers and adolescents will have content delivered together and in some modules parents/guardians/caregivers and adolescents will break out to adult-only or adolescent-only groups.

The overall objective of study is to assess the following study questions:

Question 1: Is this study feasible? Question 2: Is this intervention acceptable to the target population? Question 3: Is there preliminary evidence of hypothesized effects of the intervention, that the intervention will reduce or maintaining symptoms that fall below the clinically significant range for depression and reduce or delay actual or intended sexual risk behavior in adolescents?

The study takes a single blind, randomized pilot trial. The study takes a secondary prevention approach. The investigators collect three sets of data. First, the investigators assess feasibility by examining recruitment rates, attendance, completion, and drop-out rates, and fidelity. Second, the investigators assess acceptability by examining satisfaction data. Third, as a secondary aim, the investigators use pilot data to assess hypothesized intervention effects by examining outcomes at baseline, immediately post-intervention (2-4 weeks after the last intervention session is completed), and at four months.

Study Type

Interventional

Enrollment (Anticipated)

152

Phase

  • Phase 1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Western Cape
      • Cape Town, Western Cape, South Africa, 780
        • Caroline Kuo

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

PARENTS/GUARDIANS/CAREGIVERS

  1. 18+ years
  2. primary caregiver or the person responsible for childcare in the household on a day to day basis (as identified by the household);
  3. when more than one primary caregiver exists in the household, one will be chosen at random;
  4. lives in the household at least 4 days a week
  5. sub clinical thresholds of depressive symptoms

Adolescent inclusion criteria are:

  1. 13-15 years;
  2. concurs that the adult identified is their primary caregiver;
  3. when more than one child in the family falls within the eligible age range, one child will be chosen at random;
  4. lives in the household at least 4 days a week;
  5. sub clinical thresholds of depressive symptoms

Exclusion Criteria:

PARENTS/GUARDIANS/CAREGIVERS & Adolescents

  1. cognitive impairments that would not allow them to provide informed consent or assent;
  2. if they participated in qualitative phases of the study
  3. report no or low symptoms or clinically significant thresholds of depression -

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention
Families are randomly allocated to a behavioral intervention arm (called Our Family Our Future) focusing on reducing sexual risk behavior in adolescents and reducing or maintaining symptoms that fall below the clinically significant range for depression. Arms will be allocated using urn randomization.
The Our Family Our Future Program is a family preventive intervention that uses resilience and prevention focused strategies to reduce sexual risk behaviors and build mental wellbeing among adolescents.
No Intervention: Control
Families are randomly allocated to the control arm (which receives standard usual care, and then offered the intervention after outcome assessments as a wait-list) using urn randomization.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline in sexual behavior or intended sexual behavior at 4 months post-intervention
Time Frame: assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
as measured through lifetime and past 3 month sexual acts, condom use, HIV and STI status, prior pregnancy
assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
Change or maintenance of depressive symptoms at sub-clinical range from baseline to 4 months post-intervention measured by CES-D and CES-DC
Time Frame: assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
Self-reported depressive symptoms
assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
Intervention acceptability - satisfaction with intervention content, delivery, length using the client satisfaction questionnaire and as measured on a likert scale response and as open-ended response options
Time Frame: acceptability will be assessed during the intervention, an expected average timeframe of 4 weeks
acceptability will be assessed during the intervention, an expected average timeframe of 4 weeks
Intervention feasibility measured by attendance, retention for outcome assessments, fidelity
Time Frame: cceptability will be assessed during the intervention, an expected average timeframe of 4 weeks
cceptability will be assessed during the intervention, an expected average timeframe of 4 weeks

Secondary Outcome Measures

Outcome Measure
Time Frame
Change in resilience from baseline to 4 months post-intervention as measured through CD-RISC
Time Frame: assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
Change in depression impairment from baseline to 4 months post-intervention as measured through DISP and CPODMV
Time Frame: assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
Change in perceived HIV risk susceptibility from baseline to 4 months post-intervention using a ranking derived from a 0-100 and as measured on a likert scale response
Time Frame: assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
Change in HIV knowledge from baseline to 4 months post-intervention as measured through the HIV Knowledge Questionnaire
Time Frame: assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
Change in HIV stigma from baseline to 4 months post-intervention as measured through the HIV Knowledge Questionnaire
Time Frame: assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
Change in norms and attitudes about sex from baseline to 4 months post-intervention as measured on a likert scale response
Time Frame: assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
Change in norms and attitudes about condoms from baseline to 4 months post-intervention as measured through the condom attitudes scale and likert response questions
Time Frame: assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
Change in sexual behavior self-efficacy from baseline to 4 months post-interventionusing a ranking derived from a 0-100 and as measured on a likert scale response
Time Frame: assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
Change in anxiety from baseline to 4 months post-interventionas measured through BAI and RCMAS
Time Frame: assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
Change in psychological distress from baseline to 4 months post-intervention as measured through K6 and SDQ
Time Frame: assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
Change in trauma symptoms from baseline to 4 months post-intervention as measured through PCL and NSESSS
Time Frame: assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
Change in substance use from baseline to 4 months post-intervention as measured through AUDIT and DUDIT
Time Frame: assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
Change in hope from baseline to 4 months post-intervention as measured through BHS
Time Frame: assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
Change in social support from baseline to 4 months post-intervention as measured through MSPSS
Time Frame: assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
Change in family relationship from baseline to 4 months post-intervention as measured through Family Relationship Scale
Time Frame: assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
Change in family communication from baseline to 4 months post-intervention as measured through the Parent-adolescent Communication Scale
Time Frame: assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
Change in family communication from baseline to 4 months post-intervention as measured through the Parent-adolescent Sex Communication Scale
Time Frame: assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
Change in family relationship from baseline to 4 months post-intervention as measured through the Inventory of Parent-peer Attachment
Time Frame: assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
Change in parenting from baseline to 4 months post-interventionas measured through the Parental Monitoring Questionnaire
Time Frame: assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
Change in parenting from baseline to 4 months post-intervention as measured through the Parenting Scale
Time Frame: assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2015

Primary Completion (Actual)

July 31, 2017

Study Completion (Actual)

July 31, 2017

Study Registration Dates

First Submitted

April 19, 2015

First Submitted That Met QC Criteria

April 28, 2015

First Posted (Estimate)

May 4, 2015

Study Record Updates

Last Update Posted (Actual)

August 2, 2017

Last Update Submitted That Met QC Criteria

July 31, 2017

Last Verified

July 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • K01MH096646 (U.S. NIH Grant/Contract)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Depression

Clinical Trials on Our Family Our Future

3
Subscribe